193 related articles for article (PubMed ID: 29494595)
21. Gender differences in serum high-molecular-weight adiponectin levels in metabolic syndrome.
Eglit T; Lember M; Ringmets I; Rajasalu T
Eur J Endocrinol; 2013 Mar; 168(3):385-91. PubMed ID: 23230211
[TBL] [Abstract][Full Text] [Related]
22. Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes.
Aso Y; Takebayashi K; Wakabayashi S; Momobayashi A; Sugawara N; Terasawa T; Naruse R; Hara K; Suetsugu M; Morita K; Inukai T
Diabetes Res Clin Pract; 2010 Dec; 90(3):250-5. PubMed ID: 20888657
[TBL] [Abstract][Full Text] [Related]
23. Preatherosclerosis and adiponectin subfractions in obese adolescents.
Mangge H; Almer G; Haj-Yahya S; Pilz S; Gasser R; Möller R; Horejsi R
Obesity (Silver Spring); 2008 Dec; 16(12):2578-84. PubMed ID: 18846045
[TBL] [Abstract][Full Text] [Related]
24. Association of serum adiponectin with asthma and pulmonary function in the Japanese population.
Hayashikawa Y; Iwata M; Inomata M; Kawagishi Y; Tokui K; Taka C; Kambara K; Okazawa S; Yamada T; Hayashi R; Kamura Y; Okazawa T; Matsui S; Kigawa M; Tobe K
Endocr J; 2015; 62(8):695-709. PubMed ID: 25985757
[TBL] [Abstract][Full Text] [Related]
25. Telmisartan at 80 mg/day increases high-molecular-weight adiponectin levels and improves insulin resistance in diabetic patients.
Mori H; Okada Y; Arao T; Nishida K; Tanaka Y
Adv Ther; 2012 Jul; 29(7):635-44. PubMed ID: 22821644
[TBL] [Abstract][Full Text] [Related]
26. High Molecular Weight (HMW): total adiponectin ratio is low in hiv-infected women receiving protease inhibitors.
Omar F; Dave JA; King JA; Levitt NS; Pillay TS
BMC Clin Pathol; 2014; 14(1):46. PubMed ID: 25580091
[TBL] [Abstract][Full Text] [Related]
27. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects.
Basu R; Pajvani UB; Rizza RA; Scherer PE
Diabetes; 2007 Aug; 56(8):2174-7. PubMed ID: 17513700
[TBL] [Abstract][Full Text] [Related]
28. Middle- and high-molecular weight adiponectin levels in relation to nonalcoholic fatty liver disease.
Lian K; Feng YN; Li R; Liu HL; Han P; Zhou L; Li CX; Wang Q
J Clin Lab Anal; 2020 Apr; 34(4):e23148. PubMed ID: 31880002
[TBL] [Abstract][Full Text] [Related]
29. Adiponectin multimeric complexes and the metabolic syndrome trait cluster.
Lara-Castro C; Luo N; Wallace P; Klein RL; Garvey WT
Diabetes; 2006 Jan; 55(1):249-59. PubMed ID: 16380500
[TBL] [Abstract][Full Text] [Related]
30. Association of the + 45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women.
Mackawy AM
Gene; 2013 Nov; 530(1):158-63. PubMed ID: 23958652
[TBL] [Abstract][Full Text] [Related]
31. The proportion and metabolic effects of adiponectin multimeric isoforms in patients with chronic kidney disease on maintenance hemodialysis.
Abe Y; Eto S; Matsumae T; Ogahara S; Murata T; Watanabe M; Nakashima H; Saito T
Ren Fail; 2010; 32(7):849-54. PubMed ID: 20662699
[TBL] [Abstract][Full Text] [Related]
32. Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome.
Tamai T; Kamijo K; Abe Y; Hibino S; Sakurai S; Watanabe S; Watanabe Y; Nimura S; Shiratori A; Takayanagi T; Watanabe T; Nakano Y; Ikeda H; Dobashi K; Nakano Y; Mizuno K; Itabashi K
Clin Exp Nephrol; 2021 Sep; 25(9):1027-1034. PubMed ID: 34061287
[TBL] [Abstract][Full Text] [Related]
33. Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes.
von Eynatten M; Liu D; Bluemm A; Schuster T; Baumann M; Lutz J; Heemann U; Dugi KA; Nawroth PP; Bierhaus A; Humpert PM
Clin Endocrinol (Oxf); 2009 Jul; 71(1):27-32. PubMed ID: 18778396
[TBL] [Abstract][Full Text] [Related]
34. Maternal serum adiponectin multimers in preeclampsia.
Mazaki-Tovi S; Romero R; Vaisbuch E; Kusanovic JP; Erez O; Gotsch F; Chaiworapongsa T; Than NG; Kim SK; Nhan-Chang CL; Jodicke C; Pacora P; Yeo L; Dong Z; Yoon BH; Hassan SS; Mittal P
J Perinat Med; 2009; 37(4):349-63. PubMed ID: 19348608
[TBL] [Abstract][Full Text] [Related]
35. Associations between inflammation-related biomarkers and depressive symptoms in individuals with recently diagnosed type 1 and type 2 diabetes.
Herder C; Fürstos JF; Nowotny B; Begun A; Strassburger K; Müssig K; Szendroedi J; Icks A; Roden M;
Brain Behav Immun; 2017 Mar; 61():137-145. PubMed ID: 28041985
[TBL] [Abstract][Full Text] [Related]
36. Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects.
Liu Y; Retnakaran R; Hanley A; Tungtrongchitr R; Shaw C; Sweeney G
J Clin Endocrinol Metab; 2007 Nov; 92(11):4313-8. PubMed ID: 17698903
[TBL] [Abstract][Full Text] [Related]
37. Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes.
Jaziri R; Aubert R; Roussel R; Emery N; Maimaitiming S; Bellili N; Miot A; Saulnier PJ; Travert F; Hadjadj S; Marre M; Fumeron F;
Nephrol Dial Transplant; 2010 Jul; 25(7):2231-7. PubMed ID: 20083470
[TBL] [Abstract][Full Text] [Related]
38. Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistant adults.
O'Leary VB; Jorett AE; Marchetti CM; Gonzalez F; Phillips SA; Ciaraldi TP; Kirwan JP
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E421-7. PubMed ID: 17488807
[TBL] [Abstract][Full Text] [Related]
39. [Correlation of adiponectin in patients with type 2 diabetes with nonalcoholic fatty liver disease depending on transaminases level].
Mykhal'chyshyn HP; Bodnar PM; Kobyliak NM
Lik Sprava; 2014; (5-6):130-8. PubMed ID: 25906661
[TBL] [Abstract][Full Text] [Related]
40. Increased total and high-molecular weight adiponectin after extended-release niacin.
Plaisance EP; Grandjean PW; Brunson BL; Judd RL
Metabolism; 2008 Mar; 57(3):404-9. PubMed ID: 18249215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
